Use of an Actinobacillus Pleuropneumoniae Multiple Mutant As a Vaccine That Allows Differentiation of Vaccinated and Infected Animals.
From: Institut fuer Mikrobiologie, Zentrum fuer Infektionsmedizin, Stiftung Tierärztliche Hochschule Hannover, Bischofsholer Damm 15, 30173 Hannover, Germany.
Infection and immunity
- Publish Date: Jul 2006
- ISSN: 0019-9567
- Volume: 74
- Issue: 7
- Pages: 4124-32
- Medium: Print
- Language: English
- Citation (JAMA): Maas Alexander, Jacobsen Ilse D, Meens Jochen, et al. Use of an Actinobacillus Pleuropneumoniae Multiple Mutant As a Vaccine That Allows Differentiation of Vaccinated and Infected Animals.. Infect. Immun. Jul 2006;74:4124-32
Abstract
Vaccination against Actinobacillus pleuropneumoniae is hampered by the lack of vaccines inducing reliable cross-serotype protection. In contrast, pigs surviving natural infection are at least partially protected from clinical symptoms upon reinfection with any serotype. Thus, we set out to construct an attenuated A. pleuropneumoniae live vaccine allowing the differentiation of vaccinated from infected animals (the DIVA concept) by successively deleting virulence-associated genes. Based on an A. pleuropneumoniae serotype 2 prototype live negative marker vaccine (W. Tonpitak, N. Baltes, I. Hennig-Pauka, and G.-F. Gerlach, Infect. Immun. 70:7120-7125, 2002), genes encoding three enzymes involved in anaerobic respiration and the ferric uptake regulator Fur were deleted, resulting in a highly attenuated sixfold mutant; this mutant was still able to colonize the lower respiratory tract and induced a detectable immune response. Upon a single aerosol application, this mutant provided significant protection from clinical symptoms upon heterologous infection with an antigenically distinct A. pleuropneumoniae serotype 9 challenge strain and allowed the serological discrimination between infected and vaccinated groups.
Mesh Headings (Keywords): Actinobacillus Infections, Actinobacillus pleuropneumoniae, Animals, Bacterial Proteins, Bacterial Vaccines, Humans, Mutation, Repressor Proteins, Swine, Vaccines, Attenuated, Virulence
Check for Full Text / PubMed Unique Identifier (PMID): 16790786
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.